1 / 47

Haemodialysis Practices: Vascular Access, Blood Flow Rates, and Treatment Outcomes

This chapter examines the trends and challenges in haemodialysis practices, including vascular access, blood flow rates, and treatment outcomes. It provides valuable insights into the factors that impact the success of haemodialysis treatments.

cnichols
Download Presentation

Haemodialysis Practices: Vascular Access, Blood Flow Rates, and Treatment Outcomes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CHAPTER 11 Haemodialysis Practices CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20th MDTR Report 2012, NRR

  2. Table 11.1.1: Vascular access on haemodialysis, 1997-2012 Source: 20th MDTR Report 2012, NRR

  3. Table 11.1.2: Difficulties report with vascular access, 1997-2012 Source: 20th MDTR Report 2012, NRR

  4. Table 11.1.3: Complications reported with vascular access, 1997-2012 Source: 20th MDTR Report 2012, NRR

  5. Table 11.2.1: Blood flow rates in HD centers, 1997-2012

  6. <150 ml/min 150-199 ml/min 200-249 ml/min 250-299 ml/min 300-349 ml/min >=350 ml/min 50 40 30 % 20 10 0 '97 '98 '99 '00 '04 '07 '10 '01 '02 '03 '05 '06 '08 '09 '11 '12 Year Figure 11.2.1: Blood flow rates in HD centers, 1997-2012 Source: 20th MDTR Report 2012, NRR

  7. Table 11.2.2: Number of HD sessions per week, 1997-2012 Source: 20th MDTR Report 2012, NRR

  8. Table 11.2.3: Duration of HD, 1997-2012

  9. Table 11.2.4: Dialyser membrane types in HD centres, 1997-2012 Source: 20th MDTR Report 2012, NRR

  10. Regenerated Cellulose Modified Cellulose Hydrophilized copolymers Hydrophobic/Hypdrophilic 100 90 80 70 Percent (%) 60 50 40 30 20 10 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Year Figure 11.2.4: Dialyser membrane types in HD centres, 1997-2012 Source: 20th MDTR Report 2012, NRR

  11. Table 11.2.5: Frequency of Dialyser use in HD centres, 1997-2012 Source: 20th MDTR Report 2012, NRR

  12. Table 11.2.6(a): Distribution of prescribed Kt/V, HD patients 1997-2012 Source: 20th MDTR Report 2012, NRR

  13. Figure 11.2.6(a): Cumulative distribution of prescribed Kt/V, HD patients 1997-2012 Source: 20th MDTR Report 2012, NRR

  14. Table 11.2.6(b): Distribution of delivered Kt/V, HD patients 2006-2012 Source: 20th MDTR Report 2012, NRR

  15. Figure 11.2.6 (b): Cumulative distribution of delivered Kt/V, HD patients 2006-2012 Source: 20th MDTR Report 2012, NRR

  16. Table 11.2.6(c): Distribution of URR, HD patients 2006-2012 Source: 20th MDTR Report 2012, NRR

  17. Figure 11.2.6 (c): Cumulative distribution of URR, HD patients 2006-2012 Source: 20th MDTR Report 2012, NRR

  18. Table 11.2.7(a): Variation in median blood flow rates in HD patients, HD centres, 1997-2012 Source: 20th MDTR Report 2012, NRR

  19. Figure 11.2.7 (a): Variation in median blood flow rates in HD patients among centres 2012 Source: 20th MDTR Report 2012, NRR

  20. Table 11.2.7 (b) Proportion of patients with blood flow rates > 300 ml/min, HD centres 1997-2012 Source: 20th MDTR Report 2012, NRR

  21. Figure 11.2.7 (b): Variation in Proportion of patients with blood flow rates >= 300 ml/min among HD centres 2012. Source: 20th MDTR Report 2012, NRR

  22. Table 11.2.7 (c): Proportion of patients with 3 HD sessions per week, HD centres 1997-2012 Source: 20th MDTR Report 2012, NRR

  23. Figure 11.2.7 (c): Variation in proportion of patients with 3 HD sessions per week among HD centres 2012 Source: 20th MDTR Report 2012, NRR

  24. Table 11.2.7 (d): Median prescribed Kt/V in HD patients, HD centres 1997-2012 Source: 20th MDTR Report 2012, NRR

  25. Figure 11.2.7 (d): Variation in median prescribed Kt/V in HD patients among HD centres 2012 Source: 20th MDTR Report 2012, NRR

  26. Table 11.2.7 (e): Proportion of patients with prescribed Kt/V ≥ 1.3, 1997-2012 Source: 20th MDTR Report 2012, NRR

  27. Figure 11.2.7 (e): Variation in proportion of patients with prescribed Kt/V ≥ 1.3 among HD centres 2012 Source: 20th MDTR Report 2012, NRR

  28. Table 11.2.7 (f): Median delivered Kt/V in HD patients, HD centres 2006-2012 Source: 20th MDTR Report 2012, NRR

  29. Figure 11.2.7 (f): Variation in median delivered Kt/V in HD patients among HD centres 2012 Source: 20th MDTR Report 2012, NRR

  30. Table 11.2.7 (g): Proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2006-2012 Source: 20th MDTR Report 2012, NRR

  31. Figure 11.2.7 (g): Variation in proportion of patients with delivered Kt/V ≥ 1.2, HD centres 2012 Source: 20th MDTR Report 2012, NRR

  32. Table 11.2.7 (h): Median URR among HD patients, HD centres 2006-2012 Source: 20th MDTR Report 2012, NRR

  33. Figure 11.2.7 (h): Variation in median URR among HD patients, HD centres 2012 Source: 20th MDTR Report 2012, NRR

  34. Table 11.2.7 (i): Proportion of HD patients with URR ≥ 65%, HD centres 2006-2012 Source: 20th MDTR Report 2012, NRR

  35. Figure 11.2.7 (i): Variation in proportion of patients with URR ≥ 65% among HD centres 2012 Source: 20th MDTR Report 2012, NRR

  36. Table 11.3.1(a): Unadjusted technique survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  37. Figure 11.3.1(a): Unadjusted technique survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  38. Table 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 1993-2012 Source: 20th MDTR Report 2012, NRR

  39. Figure 11.3.1(b): Unadjusted technique survival by year of entry (censored for death & transplant), 1997-2012 Source: 20th MDTR Report 2012, NRR

  40. Table 11.3.2(a): Unadjusted technique survival by age, 1993-2012 Source: 20th MDTR Report 2012, NRR

  41. Figure 11.3.2(a): Unadjusted technique survival by age, 1997-2012 Source: 20th MDTR Report 2012, NRR

  42. Table 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 1993-2012 Source: 20th MDTR Report 2012, NRR

  43. Figure 11.3.2(b): Unadjusted technique survival by age (censored for death & transplant), 1997-2012 Source: 20th MDTR Report 2012, NRR

  44. Table 11.3.3(a): Unadjusted technique survival by diabetes status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  45. Figure 11.3.3(a): Unadjusted technique survival by diabetes status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  46. Table 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant), 1993-2012 Source: 20th MDTR Report 2012, NRR

  47. Figure 11.3.3(b): Unadjusted technique survival by diabetes status (censored for death & transplant), 1993-2012 Source: 20th MDTR Report 2012, NRR

More Related